Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Quak

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
International Journal of Cancer|February 15, 1989
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistanceH J Broxterman, H M Pinedo, C M Kuiper, et al.
Cancer Research|May 1, 1992
Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2G A van Dongen, H Leverstein, J C Roos, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 9, 2000
Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen-DR expression and interleukin-6/tumor necrosis factor-alpha response of the monocytevan Bokhorst-de van der Schuer, B M von Blomberg-van der Flier, D J Kuik, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Differences in immune status between well-nourished and malnourished head and neck cancer patientsM A van Bokhorst-De van der Schuer, B M von Blomberg-van der Flier, R K Riezebos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2R de Bree, J C Roos, J J Quak, et al.
European Journal of Nuclear Medicine|November 3, 1998
The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patientsR de Bree, D J Kuik, J J Quak, et al.
The American Journal of Clinical Nutrition|February 7, 2001
Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patientsM A van Bokhorst-De Van Der Schueren, J J Quak, B M von Blomberg-van der Flier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patientsJ W Stroomer, J C Roos, M Sproll, et al.
Annals of Human Genetics|January 31, 2003
CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian populationJ A Cavanaugh, K E Adams, E J Quak, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
International Journal of Cancer|February 15, 1989
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistanceH J Broxterman, H M Pinedo, C M Kuiper, et al.
Cancer Research|May 1, 1992
Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2G A van Dongen, H Leverstein, J C Roos, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 9, 2000
Survival of malnourished head and neck cancer patients can be predicted by human leukocyte antigen-DR expression and interleukin-6/tumor necrosis factor-alpha response of the monocytevan Bokhorst-de van der Schuer, B M von Blomberg-van der Flier, D J Kuik, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Differences in immune status between well-nourished and malnourished head and neck cancer patientsM A van Bokhorst-De van der Schuer, B M von Blomberg-van der Flier, R K Riezebos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2R de Bree, J C Roos, J J Quak, et al.
European Journal of Nuclear Medicine|November 3, 1998
The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patientsR de Bree, D J Kuik, J J Quak, et al.
The American Journal of Clinical Nutrition|February 7, 2001
Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patientsM A van Bokhorst-De Van Der Schueren, J J Quak, B M von Blomberg-van der Flier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patientsJ W Stroomer, J C Roos, M Sproll, et al.
Annals of Human Genetics|January 31, 2003
CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian populationJ A Cavanaugh, K E Adams, E J Quak, et al.
Pageof 9